Viridian Therapeutics Inc
NASDAQ:VRDN

Watchlist Manager
Viridian Therapeutics Inc Logo
Viridian Therapeutics Inc
NASDAQ:VRDN
Watchlist
Price: 22.43 USD -12.76% Market Closed
Market Cap: 1.7B USD
Have any thoughts about
Viridian Therapeutics Inc?
Write Note

Viridian Therapeutics Inc
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Viridian Therapeutics Inc
Other Current Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Viridian Therapeutics Inc
NASDAQ:VRDN
Other Current Liabilities
$288k
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
-16%
Abbvie Inc
NYSE:ABBV
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Other Current Liabilities
$11.7B
CAGR 3-Years
197%
CAGR 5-Years
551%
CAGR 10-Years
53%
Amgen Inc
NASDAQ:AMGN
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Current Liabilities
$357.6m
CAGR 3-Years
21%
CAGR 5-Years
36%
CAGR 10-Years
27%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Current Liabilities
$627.2m
CAGR 3-Years
7%
CAGR 5-Years
1%
CAGR 10-Years
24%

See Also

What is Viridian Therapeutics Inc's Other Current Liabilities?
Other Current Liabilities
288k USD

Based on the financial report for Jun 30, 2024, Viridian Therapeutics Inc's Other Current Liabilities amounts to 288k USD.

What is Viridian Therapeutics Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
-16%

Over the last year, the Other Current Liabilities growth was -4%. The average annual Other Current Liabilities growth rates for Viridian Therapeutics Inc have been -1% over the past three years , and -16% over the past ten years .

Back to Top